
🔥 The AI Chip Trade is OUT. This is in… [sponsor] [adv]
Cincinnati Financial’s quarterly profit more than doubles on higher premiums, interest income The results reflect the stability of insurance firms, even as trade tensions disrupt other businesses. As consumers and companies grow accustomed to economic uncertainty, spending on policies has remained steady.Earned premiums rose 15% to $2.48 billion, the Fairfield, Ohio-based company said.Investment incom … Read More >>
The “Forever Portfolio”: 7 stocks to buy and hold forever [sponsor]
In this market, investors are asking me if we’re about to see a massive correction… or worse. The honest answer is nobody knows. But I DO know a way to stop worrying about the market’s next move…Own a select group of stocks that can weather whatever the market has in store. These 7 stocks fit the bill. Each one had to pass rigorous testing to make the list. The result is a select group of high-quality blue-chip stocks. Click here for more details…
Analysis-EU’s $250 billion-per-year spending on US energy is unrealistic BRUSSELS/HOUSTON (Reuters) -The European Union’s pledge to buy $250 billion of U.S. energy supplies per year is unrealistic because it would require the redirection of most U.S. energy exports towards Europe and the EU has little control over the energy its companies import.The U.S. and EU struck a framework … Read More >>
What Is “The US: IPO”? [sponsor]
You won’t hear this on CNBC… but the government may soon open up hundreds of trillions in oil, gas, lithium, and land rights. Whitney Tilson breaks it all down, and shows how everyday Americans can grab a stake. His urgent new briefing explains “The US: IPO”… and how to get in before the looming federal deadline. More here.
Bank of America appoints new tech chief as Bhasin retires, memo shows Bhasin, whose career spans more than two decades at BofA, will take on a new role outside the bank advising and investing in mid-sized companies. He serves on the bank’s executive management team and held roles in technology, marketing and other areas during his tenure, according to the memo signed by CEO Bri … Read More >>
US FDA approves PTC Therapeutics’ metabolic disorder drug (Reuters) -The U.S. Food and Drug Administration has approved PTC Therapeutics’ oral drug to treat a rare inherited metabolic disorder that prevents the body from properly breaking down certain amino acids, the company said on Monday.The approval allows PTC to expand its revenue base as its top-selling Duchen … Read More >>
You Might Also Like
Strange Options Secret (NOT Day Trading!) [sponsor]
Trading Options in 2025 [sponsor]
Check out this simple options system [sponsor]
Be sure that you receive future email from Options Trading Report – please whitelist our email address with your email provider.
|